Healthcare provider profile · identity verified

Endre Agoston, MD

Hospitalist · LOMA LINDA, CA · NPI 1124439781

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1138	418
Amlodipine Besylate	Amlodipine Besylate	516	185
Levothyroxine Sodium	Levothyroxine Sodium	503	174
Lisinopril	Lisinopril	456	172
Rosuvastatin Calcium	Rosuvastatin Calcium	424	157
Losartan Potassium	Losartan Potassium	380	151
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	350	97
Atenolol	Atenolol	292	96
Omeprazole	Omeprazole	250	95
Simvastatin	Simvastatin	232	77
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	221	77
Tramadol Hcl	Tramadol Hcl	213	47
Gabapentin	Gabapentin	211	68
Metoprolol Tartrate	Metoprolol Tartrate	211	79
Trazodone Hcl	Trazodone Hcl	211	84
Tamsulosin Hcl	Tamsulosin Hcl	206	81
Metformin Hcl	Metformin Hcl	198	70
Albuterol Sulfate Hfa	Albuterol Sulfate	182	83
Pantoprazole Sodium	Pantoprazole Sodium	176	70
Meloxicam	Meloxicam	158	70
Potassium Chloride	Potassium Chloride	157	68
Metformin Hcl Er	Metformin Hcl	154	65
Pradaxa	Dabigatran Etexilate Mesylate	153	60
Ibuprofen	Ibuprofen	152	48
Hydrochlorothiazide	Hydrochlorothiazide	150	63
Glipizide	Glipizide	149	47
Furosemide	Furosemide	132	62
Alendronate Sodium	Alendronate Sodium	127	47
Lorazepam	Lorazepam	109	26
Finasteride	Finasteride	104	37
Carvedilol	Carvedilol	92	36
Terazosin Hcl	Terazosin Hcl	92	33
Allopurinol	Allopurinol	85	36
Montelukast Sodium	Montelukast Sodium	83	29
Acyclovir	Acyclovir	82	34
Triamcinolone Acetonide	Triamcinolone Acetonide	77	39
Ezetimibe	Ezetimibe	76	29
Wixela Inhub	Fluticasone Propion/Salmeterol	76	22
Alprazolam	Alprazolam	73	24
Clopidogrel	Clopidogrel Bisulfate	73	32
Pravastatin Sodium	Pravastatin Sodium	73	27
Prednisone	Prednisone	72	48
Fluoxetine Hcl	Fluoxetine Hcl	68	23
Fenofibrate	Fenofibrate	64	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	25
Mirtazapine	Mirtazapine	62	23
Duloxetine Hcl	Duloxetine Hcl	60	24
Buspirone Hcl	Buspirone Hcl	59	24
Citalopram Hbr	Citalopram Hydrobromide	57	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	20
Bupropion Hcl Sr	Bupropion Hcl	56	26
Propranolol Hcl	Propranolol Hcl	56	24
Jardiance	Empagliflozin	54	21
Bisoprolol Fumarate	Bisoprolol Fumarate	52	23
Metoprolol Succinate	Metoprolol Succinate	48	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	48	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	14
Quetiapine Fumarate	Quetiapine Fumarate	47	12
Temazepam	Temazepam	45	11
Hydralazine Hcl	Hydralazine Hcl	44	15
Ozempic	Semaglutide	44	11
Eliquis	Apixaban	43	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	17
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	41	41
Sertraline Hcl	Sertraline Hcl	41	16
Azelastine Hcl	Azelastine Hcl	40	17
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	37	14
Estradiol	Estradiol	36	15
Humulin N	Insulin Nph Human Isophane	36	13
Lovastatin	Lovastatin	35	13
Alvesco	Ciclesonide	34	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	33
Humulin N Kwikpen	Insulin Nph Human Isophane	34	11
Pregabalin	Pregabalin	34	11
Escitalopram Oxalate	Escitalopram Oxalate	33	12
Ondansetron Odt	Ondansetron	33	18
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	32	suppressed
Naltrexone Hcl	Naltrexone Hcl	32	16
Pioglitazone Hcl	Pioglitazone Hcl	30	11
Ketoconazole	Ketoconazole	28	11
Testosterone	Testosterone	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	13
Hydrocortisone	Hydrocortisone	26	13
Zolpidem Tartrate	Zolpidem Tartrate	26	11
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	14
Famotidine	Famotidine	25	13
Humulin R	Insulin Regular, Human	25	suppressed
Lactulose	Lactulose	25	12
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	12
Benazepril Hcl	Benazepril Hcl	24	suppressed
Morphine Sulfate	Morphine Sulfate	23	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	23	12
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	17
Bupropion Xl	Bupropion Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Amoxicillin	Amoxicillin	20	14
Cephalexin	Cephalexin	20	12
Nitroglycerin	Nitroglycerin	20	13
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Diazepam	Diazepam	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	14
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Cefadroxil	Cefadroxil	17	15
Naproxen	Naproxen	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Azithromycin	Azithromycin	16	16
Clonidine Hcl	Clonidine Hcl	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Cilostazol	Cilostazol	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	14	14
Fluocinonide	Fluocinonide	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Metronidazole	Metronidazole	14	12
Mupirocin	Mupirocin	14	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Fluocinolone Acetonide	Fluocinolone/Shower Cap	13	suppressed
Nystatin	Nystatin	13	suppressed
Topiramate	Topiramate	13	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Epinephrine	Epinephrine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Colchicine	Colchicine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error